Intra-articular therapies: patient preferences and professional practices in European countries
Por:
De la Torre-Aboki, J, Uson, J, Pitsillidou, I, Vardanyan, V, Nikiphorou, E, Rodriguez-Garcia, S, Castellanos-Moreira, R, Pandit, H, O'Neill, T, Doherty, M, Boesen, M, Moller, I, Terslev, L, D'Agostino, M, Kampen, W, Berenbaum, F, Naredo, E and Carmona, L
Publicada:
1 may 2022
Ahead of Print:
1 nov 2021
Resumen:
To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.
Filiaciones:
:
Hosp Gen Univ, Hosp Dia, Alicante, Spain
Hosp Gen Univ, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Alicante, Spain
Uson, J:
Univ Rey Juan Carlos, Hosp Univ Mostoles, Dept Rheumatol, Madrid, Spain
Pitsillidou, I:
Execut Secretary Cyprus League Rheumatism, Nicosia, Cyprus
Vardanyan, V:
Yerevan State Med Univ, Mikayelyan Univ Hosp, Yerevan, Armenia
Nikiphorou, E:
Kings Coll London, Kings Coll Hosp, Fac Life Sci & Med, Rheumatol Dept,Dept Inflammat Biol,Ctr Rheumat Di, London, England
Rodriguez-Garcia, S:
La Princesa Univ Hosp, Rheumatol Dept, Madrid, Spain
Castellanos-Moreira, R:
Hosp Clin I Prov, Barcelona, Spain
Pandit, H:
Univ Leeds, Leeds, W Yorkshire, England
O'Neill, T:
Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England
Manchester Univ NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
Doherty, M:
Univ Nottingham, Nottingham, England
Boesen, M:
Copenhagen Univ Hosp Bispebjerg Frederiksberg, Dept Radiol, Frederiksberg, Denmark
Moller, I:
Univ Barcelona, Inst Poal Reumatol, Barcelona, Spain
Terslev, L:
Rigshosp, Ctr Rheumatol & Spine Dis, Glostrup, Denmark
D'Agostino, M:
Univ Cattolica Sacro Cuore, Policlin Univ A Gemelli IRCCS, Rome, Italy
Kampen, W:
Radiol Allianz, Nukl Med Spitalerhof, Hamburg, Germany
Berenbaum, F:
Sorbonne Univ, St Antoine Hosp, AP HP, Dept Rheumatol,INSERM CRSA, Paris, France
Naredo, E:
Univ Fdn Jimenez Diaz, IIS Fdn Jimenez Diaz, Joint & Bone Res Unit Hosp, Dept Rheumatol, Madrid, Spain
Univ Autonoma Madrid, Madrid, Spain
Carmona, L:
InMusc, Inst Salud Musculoesquelet, Calle Ofelia Nieto 10, Madrid 28039, Spain
Bronze
|